Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kinross Gold Corp T.K

Alternate Symbol(s):  KGC

Kinross Gold Corporation is a Canada-based global senior gold mining company with operations and projects in the United States, Brazil, Mauritania, Chile and Canada. The Company’s projects include Fort Knox, Round Mountain, Bald Mountain, Manh Choh, Paracatu, La Coipa, Lobo-Marte, Tasiast and Great Bear projects. Fort Knox is an open-pit gold mine located near the city of Fairbanks, Alaska. Round Mountain is a long-life, open pit mine located in Nevada. Bald Mountain is an open pit mine with an estimated mineral resource base located in Nevada along the southern extension of the prolific Carlin trend. Manh Choh project is in Alaska, located approximately 400 kilometers southeast of Fort Knox. Paracatu is a long life, cornerstone operation located near the city of Paracatu in Brazil’s Minas Gerais region. It operates the La Coipa mine in the Atacama region and owns the Lobo-Marte development project, which is located approximately 50 kilometers southeast of La Coipa.


TSX:K - Post by User

Bullboard Posts
Comment by 13thon Feb 13, 2008 4:58am
365 Views
Post# 14364074

RE: I need an Honest Opinion ....

RE: I need an Honest Opinion ....Photobucket"""-----INNEXUS BIOTECHNOLOGY INC ( IXS.V )-----"""size=4>color=RED> MAJOR NEWS----InNexus says study shows DXL625 kills tumour cellssize=4> INNEXUS BIOTECHNOLOGY ( TRADING JUST AT 0.35 CENTS ) ANNOUNCES PRELIMINARY RESULTS OF ANIMAL STUDY COMPARING CANCER KILLING ACTIVITY OF ITS DXL625 (CD20) TREATMENT FOR NON-HODGKIN'S LYMPHOMA WITH LEADING MARKETED PRODUCT UP 200% AND RISING FAST,,HEDGE FUNDS ARE BUYING LARGEsize=4>color=RED> https://stockcharts.com/h-sc/ui?s=ixs.V&p=D&b=5&g=0&id=p95524307080 -PENDING NEWS OF 30 MILLION ROYALTY @ PRICE OF $ 1.01 GANA MAKE THIS STOCK FLY -DXL 625 is IXS's first drug offering that enhances or betters Rituxan a $2.06 Billion a year drug. -The animal testing results show that DXL 625 is more effective than Rituxan (remember a $2 Billion drug). -The CEO has indicated a 2nd drug is in the works and another $30 Million from Royalty will be soon be available to company @ price of $ 1.01 per share Show me another Biotech with this much going for it with such a low market cap. This thing is going to take off.------------- Recommandation *STRONG BUY* --------------size=4> THIS STOCK IS AT THE TOP OF THE PHARMACEUTICAL WORLD - PLACE YOUR BETS BUY LOW BEFORE HEADING TO DA MOOOOOOOOOON
Bullboard Posts